Aguinaga-Ontoso, I.; Guillen-Aguinaga, S.; Guillen-Aguinaga, L.; Alas-Brun, R.; Guillen-Aguinaga, M.; Onambele, L.; Aguinaga-Ontoso, E.; Rayón-Valpuesta, E.; Guillen-Grima, F.
The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023). Vaccines 2025, 13, 6.
https://doi.org/10.3390/vaccines13010006
AMA Style
Aguinaga-Ontoso I, Guillen-Aguinaga S, Guillen-Aguinaga L, Alas-Brun R, Guillen-Aguinaga M, Onambele L, Aguinaga-Ontoso E, Rayón-Valpuesta E, Guillen-Grima F.
The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023). Vaccines. 2025; 13(1):6.
https://doi.org/10.3390/vaccines13010006
Chicago/Turabian Style
Aguinaga-Ontoso, Ines, Sara Guillen-Aguinaga, Laura Guillen-Aguinaga, Rosa Alas-Brun, Miriam Guillen-Aguinaga, Luc Onambele, Enrique Aguinaga-Ontoso, Esperanza Rayón-Valpuesta, and Francisco Guillen-Grima.
2025. "The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)" Vaccines 13, no. 1: 6.
https://doi.org/10.3390/vaccines13010006
APA Style
Aguinaga-Ontoso, I., Guillen-Aguinaga, S., Guillen-Aguinaga, L., Alas-Brun, R., Guillen-Aguinaga, M., Onambele, L., Aguinaga-Ontoso, E., Rayón-Valpuesta, E., & Guillen-Grima, F.
(2025). The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023). Vaccines, 13(1), 6.
https://doi.org/10.3390/vaccines13010006